Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 1;43(8):789-794.
doi: 10.1097/INF.0000000000004366. Epub 2024 May 17.

Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms

Collaborators, Affiliations

Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms

Athiporn Rungsapphaiboon et al. Pediatr Infect Dis J. .

Abstract

Introduction: Dolutegravir (DTG) dispersible tablet (DTG-DT) is a pediatric-friendly formulation. We aimed to describe the pharmacokinetics and virologic responses of generic DTG-DT in children weighing <20 kg.

Methods: Children living with HIV-1 and <7 years of age weighing 6 to <20 kg were eligible. A generic 10-mg scored DTG-DT was administered to children using 3 weight bands (WB): WB1 (6 to <10 kg), WB2 (10 to <14 kg) and WB3 (14 to <20 kg), at doses of 20 mg (higher than World Health Organization recommendation of 15 mg), 20 mg and 25 mg, respectively. Steady-state intensive pharmacokinetics (PK) was performed in fasting condition with blood sampling at predose and 1, 2, 3, 4, 6 and 24 hours postdose. DTG PK parameters were estimated using a noncompartmental analysis, and DTG trough concentrations (C 24 ) and 24-hour area under the concentration-time curve were calculated. Comparisons were made with ODYSSEY and IMPAACT 2019. And 90% effective concentration of 0.32 mg/L was used as a reference individual DTG C 24 concentration.

Results: From August 2021 to March 2023, 29 Thai children with a median (interquartile range) age of 3.2 (1.5-4.8) years were enrolled; 8 in WB1, 9 in WB2 and 12 in WB3. All children were treatment experienced and 59% had HIV RNA <200 copies/mL. Overall geometric mean (coefficient of variation percentage) DTG C 24 was 1.0 (46%) mg/L [WB1, 0.9 (53%); WB2, 0.9 (27%); WB3, 1.2 (51%)]. Geometric mean (coefficient of variation percentage) 24-hour area under the concentration-time curve was 83.2 (24%) mg h/L [WB1, 84.3 (31%); WB2, 76.9 (16%); WB3, 87.6 (25%)]. At weeks 24 and 48, 90% and 92% of participants had plasma HIV RNA <200 copies/mL.

Conclusions: Generic DTG-DT provided adequate drug exposure in children weighing 6 to <20 kg. The exploratory dose of DTG 20 mg for children weighing 6 to <10 kg showed similar PK parameters to World Health Organization doses in the other WB.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1.
FIGURE 1.
Geometric means plasma DTG concentration-time profile of the 3 weight bands in children 3 months to <7 years old weighing 6 to <20 kg.
FIGURE 2.
FIGURE 2.
Individual DTG C24 (A), Cmax (B) and AUC0-24h (C) of children per each weight band. Black lines indicate geometric means of each parameter. Black dash lines indicate geometric mean adult reference value for 50 mg film-coated tablet once daily. Gray line indicates EC90; the effective concentration at which 90% of maximal viral inhibition is achieved in a 10-day monotherapy study.

References

    1. World Health Organization. The Global Health Observatory: Explore a World of Health Data: HIV. 2022. Available at: https://www.who.int/data/gho/data/themes/hiv-aids#:~:text=Globally%2C%20.... Accessed July 16, 2022.
    1. Clinton Health Access Initiative. Groundbreaking Agreement Reduces by 75% the Cost of HIV Treatment for Children in Low- and Middle-income Countries. 2022. Available at: https://www.clintonhealthaccess.org/groundbreaking-agreement-reduces-by-.... Accessed April 10, 2022.
    1. Min S, Sloan L, DeJesus E, et al. . Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults. AIDS. 2011;25:1737–1745. - PubMed
    1. UNICEF. Paediatric Care and Treatment. 2023. Available at: https://data.unicef.org/topic/hivaids/paediatric-treatment-and-care/. Accessed April 10, 2022.
    1. Ruxrungtham K, Chokephaibulkit K, Chetchotisakd P, et al. . Thailand National Guidelines on HIV/AIDS Treatment and Prevention 2021/2022. Nonthaburi: Division of AIDS and STIs, Department of Disease Control; 2022.

MeSH terms